152 related articles for article (PubMed ID: 8177980)
1. Vitamin D and the hematolymphopoietic tissue: a 1994 update.
Manolagas SC; Yu XP; Girasole G; Bellido T
Semin Nephrol; 1994 Mar; 14(2):129-43. PubMed ID: 8177980
[TBL] [Abstract][Full Text] [Related]
2. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
3. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
5. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
[TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
8. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
9. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
Kong J; Li YC
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E916-24. PubMed ID: 16368784
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
D'Ambrosio D; Cippitelli M; Cocciolo MG; Mazzeo D; Di Lucia P; Lang R; Sinigaglia F; Panina-Bordignon P
J Clin Invest; 1998 Jan; 101(1):252-62. PubMed ID: 9421488
[TBL] [Abstract][Full Text] [Related]
13. Effects of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells.
González-Sancho JM; Larriba MJ; Ordóñez-Morán P; Pálmer HG; Muñoz A
Anticancer Res; 2006; 26(4A):2669-81. PubMed ID: 16886677
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D compounds: activity against microbes and cancer.
Gombart AF; Luong QT; Koeffler HP
Anticancer Res; 2006; 26(4A):2531-42. PubMed ID: 16886661
[TBL] [Abstract][Full Text] [Related]
15. Effects of 1,25(OH)2D3, EB1089, and analog V on PTHrP production, PTHrP mRNA expression and cell growth in SCC 2/88.
Kunakornsawat S; Rosol TJ; Capen CC; Middleton RP; Hannah SS; Inpanbutr N
Anticancer Res; 2001; 21(5):3355-63. PubMed ID: 11848494
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and bone.
Stern PH
Kidney Int Suppl; 1990 Sep; 29():S17-21. PubMed ID: 2170734
[TBL] [Abstract][Full Text] [Related]
18. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production.
Provvedini DM; Tsoukas CD; Deftos LJ; Manolagas SC
J Immunol; 1986 Apr; 136(8):2734-40. PubMed ID: 3007606
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice.
Mathieu C; Van Etten E; Gysemans C; Decallonne B; Kato S; Laureys J; Depovere J; Valckx D; Verstuyf A; Bouillon R
J Bone Miner Res; 2001 Nov; 16(11):2057-65. PubMed ID: 11697802
[TBL] [Abstract][Full Text] [Related]
20. 1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes.
Karmali R; Hewison M; Rayment N; Farrow SM; Brennan A; Katz DR; O'Riordan JL
Immunology; 1991 Dec; 74(4):589-93. PubMed ID: 1783418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
